Groups want FDA to leave Avastin alone
James G. Dickinson
September 15 2010
Two breast cancer treatment advocacy groups have written to FDA asking that the agency refrain from changing the approved labeling ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.